FindTrial
Sign In

Management status and clinical intervention of postherpetic neuralgia

Management status and clinical intervention of postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023730
Enrollment
Unknown
Registered
2019-06-09
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Experimental group:Routine treatment plus Inhalation of dilute nitrous oxide
Control group:Routine treatment

Sponsors

Wenqiang Bao
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and above; 2. Postherpetic neuralgia (VAS=4); 3. Multi-functional ecg monitor or pulse oxygen monitor is allowed for the condition; 4. Can correctly understand and use longhai tongruler to express pain degree; 5. Patients and their families voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: Intestinal obstruction. Air embolism; Pneumothorax.Epilepsy; Upper respiratory tract infection; Obstructive pulmonary disease; Otolaryngological diseases (sinusitis, otitis media, periosteum transplantation)

Design outcomes

Primary

MeasureTime frame
Pain intensity;—

Countries

China

Contacts

Public ContactWenqiang Bao

General Hospital of Ningxia Medical University

baowenqiang@163.com+86 13895191737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026